These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14997039)

  • 1. Persistence of MHC DR nonexpression on swine cells by introduction of a mutated MHC class II transactivator gene: a comparison with the effect induced by antisense RNA.
    Ou Q; Lin L; Huang L; Chen F; Wu K; Lu P; Zhang J; Chou KY
    J Clin Immunol; 2004 Jan; 24(1):97-106. PubMed ID: 14997039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of human anti-porcine T-cell immune responses by major histocompatibility complex class II transactivator constructs lacking the amino terminal domain.
    Yun S; Gustafsson K; Fabre JW
    Transplantation; 1998 Jul; 66(1):103-11. PubMed ID: 9679829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction of mutants of MHC class II molecule transactivator gene capable of suppressing HLA-DR/DQ expression and exploration on their mechanism].
    Ou QS; Lin L; Huang LD; Lu PH; Zhou GY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):417-20. PubMed ID: 15169643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutated major histocompatibility complex class II transactivator up-regulates interleukin-33-dependent differentiation of Th2 subset through Nod2 binding for NLR (NOD-like receptor) signaling initiation.
    Yang Z; Gu P; Shao X; Li Z; Zhou Y; Lu L; Chou KY
    J Biol Chem; 2012 Mar; 287(13):9972-9981. PubMed ID: 22294690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
    Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.
    Zhou X; Jiang Y; Lu L; Ding Q; Jiao Z; Zhou Y; Xin L; Chou KY
    Immunology; 2007 Dec; 122(4):476-85. PubMed ID: 17645498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Major histocompatibility complex class II transactivator (CIITA) hammer- head ribozyme transfer inhibits major histocompatibility complex class II (MHC-II) expression in Jukart cells].
    Guo R; Zou P; Song YP; Ma J; Lu HZ; Cao YL; Tong YJ
    Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):925-8. PubMed ID: 14723817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells.
    Liu A; Takahashi M; Toba K; Zheng Z; Hashimoto S; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    Hematol Oncol; 1999 Dec; 17(4):149-60. PubMed ID: 10725870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
    J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III.
    Holling TM; van der Stoep N; Quinten E; van den Elsen PJ
    J Immunol; 2002 Jan; 168(2):763-70. PubMed ID: 11777970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression.
    Balducci-Silano PL; Suzuki K; Ohta M; Saito J; Ohmori M; Montani V; Napolitano G; Shong M; Taniguchi SI; Pietrarelli M; Lavaroni S; Mori A; Singer DS; Kohn LD
    Endocrinology; 1998 May; 139(5):2300-13. PubMed ID: 9564838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The induction of major histocompatibility complex class II expression is sufficient for the direct activation of human CD4+ T cells by porcine vascular endothelial cells.
    Yun S; Rose ML; Fabre JW
    Transplantation; 2000 Mar; 69(5):940-4. PubMed ID: 10755554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA; Rimsza LM; Murphy SP
    Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class II transactivator (CIITA) isoform expression and activity in melanoma.
    Baton F; Deruyffelaere C; Chapin M; Prod'homme T; Charron D; Al-Daccak R; Alcaide-Loridan C
    Melanoma Res; 2004 Dec; 14(6):453-61. PubMed ID: 15577315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
    Meissner M; Whiteside TL; Kaufmann R; Seliger B
    Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells.
    Morimoto Y; Toyota M; Satoh A; Murai M; Mita H; Suzuki H; Takamura Y; Ikeda H; Ishida T; Sato N; Tokino T; Imai K
    Br J Cancer; 2004 Feb; 90(4):844-52. PubMed ID: 14970863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA.
    Lüder CG; Lang C; Giraldo-Velasquez M; Algner M; Gerdes J; Gross U
    J Neuroimmunol; 2003 Jan; 134(1-2):12-24. PubMed ID: 12507768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly efficient peptide binding and T cell activation by MHC class II molecules of CIITA-transfected cells.
    Martinez-Soria E; Siegrist CA; Mach B
    Int Immunol; 1996 Apr; 8(4):543-9. PubMed ID: 8671641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enhanced anti-tumor effect of dendritic cells modified by CIITA gene in hepatocellular carcinoma-bearing mice].
    Ou QS; Lin Q; Lan B; Guo CR
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Sep; 21(5):580-2, 586. PubMed ID: 16143061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.